Team:HUST-China/Protocol
From 2014.igem.org
(37 intermediate revisions not shown) | |||
Line 70: | Line 70: | ||
a:hover { | a:hover { | ||
color: #0099cc;; | color: #0099cc;; | ||
+ | } | ||
+ | |||
+ | #apDiv_Logo_iGEM { | ||
+ | position:absolute; | ||
+ | right:30px; | ||
+ | top:-20px; | ||
+ | width: 100px; | ||
+ | height: 100px; | ||
+ | z-index: 1; | ||
} | } | ||
Line 132: | Line 141: | ||
<div class="chapter"> | <div class="chapter"> | ||
- | <span>Protocol</span> | + | <span><font size="6px">Protocol</span></font> |
- | <h1 align="left" id="h2_0"><a name="Top" id="Top"></a><a name="Part_1" id="Part_1"></a | + | <h1 align="left" id="h2_0"><a name="Top" id="Top"></a><a name="Part_1" id="Part_1"></a>Part 1: The Construction of the Worker System</h1> |
- | + | <h3 align="left">Step 1: Gene Cloning</h3></p> | |
- | + | <p>To find the optimal temperature for oprF and <em>cyn</em>RTS composite amplification, we set a gradient of annealing temperature. The result shows that 58℃ is suitable to this PCR. The PCR product was stored in -20℃. The PCR reaction system was listed in table 1-1.</p> | |
- | + | <h3 align="center">Table 1-1 Gradient PCR System</h3> | |
- | + | <table border="1" cellpadding="1" cellspacing="0" width="800"> | |
- | To find the optimal temperature for oprF and <em>cyn</em>RTS composite amplification, we set a gradient of annealing temperature. The result shows that 58℃ is suitable to this PCR. The PCR product was stored in -20℃. The PCR reaction system was listed in table 1-1.</p> | + | |
- | < | + | |
- | <table border="1" cellpadding="1" cellspacing="0" width="800"> | + | |
<tr> | <tr> | ||
<td>Components(50μl)</td> | <td>Components(50μl)</td> | ||
Line 175: | Line 181: | ||
</tr> | </tr> | ||
</table> | </table> | ||
- | < | + | <br> |
- | We choose the 188aa or 196aa of OprF as the CBP fusion points. Primers were designed (Table1-2) to clone the target fragment, and then the GS linker and/or the gene fragment coding CBP were added at the C-terminal of the target fragment.< | + | <h3 align="left">Step 2: Optimization of oprF</h3></p> |
- | The protein with GS linker, using the 188aa as CBP fusion point, was named as OprF-1. While the protein without GS linker, using the 196aa as CBP fusion point, was named as OprF-2.</p> | + | <p>We choose the 188aa or 196aa of OprF as the CBP fusion points. Primers were designed (Table1-2) to clone the target fragment, and then the GS linker and/or the gene fragment coding CBP were added at the C-terminal of the target fragment.</p> |
- | < | + | <p>The protein with GS linker, using the 188aa as CBP fusion point, was named as OprF-1. While the protein without GS linker, using the 196aa as CBP fusion point, was named as OprF-2.</p> |
- | <table border="1" cellpadding="1" cellspacing="0"> | + | <h3 align="center">Table 1-2 Primers of Optimization oprF </h2> |
+ | <table border="1" cellpadding="1" cellspacing="0"> | ||
<tr> | <tr> | ||
<td width="94">Primer </td> | <td width="94">Primer </td> | ||
Line 213: | Line 220: | ||
</tr> | </tr> | ||
</table> | </table> | ||
- | < | + | <h3 align="left">Step 3: Construction of Vectors</h3></p> |
- | + | ||
<p>pET28a vector and the PCR product were digested with EcoRI and NotI from Takara, and then retrieved and purified with DNA retrieve kits from Omega.</p> | <p>pET28a vector and the PCR product were digested with EcoRI and NotI from Takara, and then retrieved and purified with DNA retrieve kits from Omega.</p> | ||
<p>Then, pET28a(+) vector, gene oprF-1/oprF-2/<em>cyn</em>RTS composite were linked together with T4 ligase to form a new vector: pET28a(+)-oprF-1/oprF-2/RTS. The reaction system for digestion and conjunction were listed in the table 1-3, 1-4 and the digestion results were displayed in fig1-1.</p> | <p>Then, pET28a(+) vector, gene oprF-1/oprF-2/<em>cyn</em>RTS composite were linked together with T4 ligase to form a new vector: pET28a(+)-oprF-1/oprF-2/RTS. The reaction system for digestion and conjunction were listed in the table 1-3, 1-4 and the digestion results were displayed in fig1-1.</p> | ||
- | < | + | <h3 align="center">Table 1-3 Reaction System for Digestion</h3> |
<table border="1" cellpadding="1" cellspacing="0" width="800"> | <table border="1" cellpadding="1" cellspacing="0" width="800"> | ||
<tr> | <tr> | ||
Line 252: | Line 258: | ||
</tr> | </tr> | ||
</table> | </table> | ||
- | < | + | <h3 align="center">Table 1-4 for Gene Conjunction</h3> |
<table border="1" cellpadding="1" cellspacing="0" width="800px"> | <table border="1" cellpadding="1" cellspacing="0" width="800px"> | ||
<tr> | <tr> | ||
Line 275: | Line 281: | ||
</tr> | </tr> | ||
</table> | </table> | ||
- | < | + | <br> |
- | < | + | <h3 align="center">Fig 1-1 Digested gene and plasmid</h3> |
- | < | + | <img src="https://static.igem.org/mediawiki/2014/d/d6/HUST_protocol_01.png" width="400" height="350"/></td> |
- | + | ||
- | < | + | |
- | < | + | <h3 align="left">Step 4: Transforming the Plasmids into <em>E. coli</em> BL21 Strain </h3></p> |
- | < | + | |
<p>Step 4: Transforming the Plasmids into <em>E. coli </em>BL21 Strain </p> | <p>Step 4: Transforming the Plasmids into <em>E. coli </em>BL21 Strain </p> | ||
- | <p>Plasmids pET28a(+)-oprF-1 or pET28a(+)-oprF-2 or pET28a(+)-flA was transformed into E. coli BL21(DE3) and protein expression was analyzed.The strains were grown in LB medium containing 100ug/ml kanamycin at 37℃, 250rpm until OD600 reached 0.4–0.6. We then added IPTG to 0.5mM and continued the incubation at 28℃ overnight to induce the overexpression of OprF-CBP or OprF-GS-CBP or flA. The cells were collected, re-suspended with 10mM imidazole containing 0.1mM protease inhibitor PMSF and then disrupted using Selecta Sonopuls. After centrifugation, the sediment was treated with 1xSDS gel loading buffer and kept in boiling water for 5 minutes and applied to SDS-PAGE. The result was displayed in Fig 1-4.</p> | + | <p>Plasmids pET28a(+)-oprF-1 or pET28a(+)-oprF-2 or pET28a(+)-flA was transformed into <em>E. coli</em> BL21(DE3) and protein expression was analyzed.The strains were grown in LB medium containing 100ug/ml kanamycin at 37℃, 250rpm until OD600 reached 0.4–0.6. We then added IPTG to 0.5mM and continued the incubation at 28℃ overnight to induce the overexpression of OprF-CBP or OprF-GS-CBP or flA. The cells were collected, re-suspended with 10mM imidazole containing 0.1mM protease inhibitor PMSF and then disrupted using Selecta Sonopuls. After centrifugation, the sediment was treated with 1xSDS gel loading buffer and kept in boiling water for 5 minutes and applied to SDS-PAGE. The result was displayed in Fig 1-4.</p> |
- | < | + | <h3 align="center">Table 1-5 Reaction System of Colonial PCR validation</h3> |
<table border="1" cellpadding="1" cellspacing="0" width="800"> | <table border="1" cellpadding="1" cellspacing="0" width="800"> | ||
<tr> | <tr> | ||
Line 311: | Line 316: | ||
</tr> | </tr> | ||
</table> | </table> | ||
- | < | + | <h3 align="center">Table 1-6 Reaction System of Double Digestion (37 ℃ 1h)</h3> |
<table border="1" cellpadding="1" cellspacing="0"> | <table border="1" cellpadding="1" cellspacing="0"> | ||
<tr> | <tr> | ||
Line 338: | Line 343: | ||
</tr> | </tr> | ||
</table> | </table> | ||
- | + | ||
- | + | <img src="https://static.igem.org/mediawiki/2014/1/1f/HUST_protocol_02.png" width="400" height="350" /></td> | |
- | + | <h3 align="center">Fig 1-2 Gel images of novel plasmids with OprF-CBP/GS-CBP testified results</h3> | |
- | < | + | <br> |
- | + | ||
- | + | ||
- | < | + | |
- | + | ||
<img src="https://static.igem.org/mediawiki/2014/5/55/HUST_protocol_03.png" width="400" height="350" /></td></tr></table> | <img src="https://static.igem.org/mediawiki/2014/5/55/HUST_protocol_03.png" width="400" height="350" /></td></tr></table> | ||
- | < | + | <h3 align="center">Fig 1-3 Gel images of novel plasmids with <em>cyn</em>RTS composite testified results</h3> |
+ | <br> | ||
<p>The <em>E. coli</em> BL21(DE3) strain transformed with pET28a(+)-flA was kindly donated by Prof. David O'Hagan and Prof. James H. Naismith from University of St Andrews, Saint Andrews, Scotland, United Kingdom. </p> | <p>The <em>E. coli</em> BL21(DE3) strain transformed with pET28a(+)-flA was kindly donated by Prof. David O'Hagan and Prof. James H. Naismith from University of St Andrews, Saint Andrews, Scotland, United Kingdom. </p> | ||
- | < | + | <h3 align="left">Step 5: Expression of Protein</h3> |
+ | <p> | ||
Plasmid pET28a(+)-oprF-1/oprF-2/<em>cyn</em>RTS composite/flA was transformed into <em>E. coli</em> BL21(DE3) and we get for protein expression analysis. The strains were grown in Luria broth containing 100ug/ml kanamycin at 37℃, 250rpm until an absorbance of 0.4–0.6 at 600 nm was reached. We then added IPTG to 0.5mM and continued the incubation at 28℃ overnight to induce the overexpression of OprF-CBP/OprF-GS-CBP. The cells were collected, suspended with 10mM imidazole containing 0.1mM protease inhibitor PMSF and then disrupted using Selecta Sonopuls. After centrifugation, the sediment was treated with 1*SDS gel loading buffer and kept in boiling water for 5 minutes and applied to SDS-PAGE. </p> | Plasmid pET28a(+)-oprF-1/oprF-2/<em>cyn</em>RTS composite/flA was transformed into <em>E. coli</em> BL21(DE3) and we get for protein expression analysis. The strains were grown in Luria broth containing 100ug/ml kanamycin at 37℃, 250rpm until an absorbance of 0.4–0.6 at 600 nm was reached. We then added IPTG to 0.5mM and continued the incubation at 28℃ overnight to induce the overexpression of OprF-CBP/OprF-GS-CBP. The cells were collected, suspended with 10mM imidazole containing 0.1mM protease inhibitor PMSF and then disrupted using Selecta Sonopuls. After centrifugation, the sediment was treated with 1*SDS gel loading buffer and kept in boiling water for 5 minutes and applied to SDS-PAGE. </p> | ||
- | < | + | <h3 align="left">Step 6: Surface Displaying Copper Ions</h3> |
+ | <p> | ||
To identify that whether our OprF has anchored on the cell membrane of <em>E. coli</em>, we performed immunofluorescence assay. HA tag was added to the N-terminal of OprF-CBP so that the recombinant protein OprF-CBP-HA can be specifically recognized by anti-HA antibody. When FITC labeled anti-IgG antibody was used as the secondary antibody and interacted with the primary antibody, green fluorescence could be observed in the cell membrane of <em>E. coli</em> under the fluorescent microscope.</p> | To identify that whether our OprF has anchored on the cell membrane of <em>E. coli</em>, we performed immunofluorescence assay. HA tag was added to the N-terminal of OprF-CBP so that the recombinant protein OprF-CBP-HA can be specifically recognized by anti-HA antibody. When FITC labeled anti-IgG antibody was used as the secondary antibody and interacted with the primary antibody, green fluorescence could be observed in the cell membrane of <em>E. coli</em> under the fluorescent microscope.</p> | ||
- | <a name="Part_2" id="Part_2"></a | + | <br> |
- | <p>All the parts except PpcoA we used to construct <em>E. instructor</em> are from kits in Distribution 2013.They are listed in table2-1.</p> | + | <br><br> |
- | < | + | <h1 align="left" id="h2_1"><a name="Part_2" id="Part_2"></a>Part 2: The Construction of the Instructor System</h1> |
+ | <br> | ||
+ | <p>All the parts except PpcoA we used to construct <em>E. instructor</em> are from kits in Distribution 2013.They are listed in table2-1.</p> | ||
+ | <h3 align="center">Table 2-1 Parts from Kits in Distribution 2013</h3> | ||
<table border="1" cellpadding="1" cellspacing="0"> | <table border="1" cellpadding="1" cellspacing="0"> | ||
<tr> | <tr> | ||
Line 400: | Line 407: | ||
</tr> | </tr> | ||
</table> | </table> | ||
- | < | + | <h3>Assemble all the elements via standard restrict sites:</h3> |
- | < | + | <h4 align="left">1. PCR: PpcoA (add EcoRI, XbaI, SpeI and PstI restriction sites)</h4> |
<img src="https://static.igem.org/mediawiki/2014/d/d3/HUST_protocol_05.png"></img> | <img src="https://static.igem.org/mediawiki/2014/d/d3/HUST_protocol_05.png"></img> | ||
- | < | + | <br> |
+ | <br> | ||
+ | <br> | ||
+ | <h4 align="left">2. Double digestion: PpcoA PCR products and rbs+CII(LVA)+ter+ter/pSB1C3(BBa_P0153):</h4> | ||
<img src="https://static.igem.org/mediawiki/2014/9/95/HUST_protocol_06.png"></img> | <img src="https://static.igem.org/mediawiki/2014/9/95/HUST_protocol_06.png"></img> | ||
- | < | + | <br> |
+ | <br> | ||
+ | <br> | ||
+ | <h4 align="left">3. Colony PCR Validation (primer PpcoA F and PpcoA R):</h4> | ||
<img src="https://static.igem.org/mediawiki/2014/6/63/HUST_protocol_07.png"></img> | <img src="https://static.igem.org/mediawiki/2014/6/63/HUST_protocol_07.png"></img> | ||
- | < | + | <h5>The plasmid pPcoA-rbs+CII+LVA/pSB1C3 was extracted and sequenced.</h5> |
- | < | + | <br> |
+ | <br> | ||
+ | <br> | ||
+ | <h4 align="left">4. Double digestion: PpcoA-rbs+CII+LVA/pSB1C3 and rbs+CI+tag-dT:</h4> | ||
<img src="https://static.igem.org/mediawiki/2014/f/f2/HUST_protocol_08.png"></img> | <img src="https://static.igem.org/mediawiki/2014/f/f2/HUST_protocol_08.png"></img> | ||
- | < | + | <br> |
+ | <br> | ||
+ | <br> | ||
+ | <h4 align="left">5. Colony PCR Validation(primer PpcoA F and cI R):</h4> | ||
<img src="https://static.igem.org/mediawiki/2014/3/39/HUST_protocol_09.png"></img> | <img src="https://static.igem.org/mediawiki/2014/3/39/HUST_protocol_09.png"></img> | ||
- | < | + | <h5 align="center">The plasmid PpcoA-rbs+CII+LVA-rbs+CI+tag-dT/pSB1C3 was extracted and sequenced.</h4> |
- | < | + | <br> |
+ | <br> | ||
+ | <br> | ||
+ | <h4 align="left">6. Double digestion: PCR product of rbs+mRFP+tag and dT/pSB1C3:</h4> | ||
<img src="https://static.igem.org/mediawiki/2014/7/70/HUST_protocol_10.png"></img> | <img src="https://static.igem.org/mediawiki/2014/7/70/HUST_protocol_10.png"></img> | ||
- | < | + | <br> |
+ | <br> | ||
+ | <br> | ||
+ | <h4 align="left">7. Colony PCR Validation (primer mRFP F1 and mRFP R1):</h4> | ||
<img src="https://static.igem.org/mediawiki/2014/5/59/HUST_protocol_11.png"></img> | <img src="https://static.igem.org/mediawiki/2014/5/59/HUST_protocol_11.png"></img> | ||
<p>The plasmid rbs+mRFP+tag-dT/pSB1C3 were extracted and sequenced.</p> | <p>The plasmid rbs+mRFP+tag-dT/pSB1C3 were extracted and sequenced.</p> | ||
- | < | + | <br> |
+ | <br> | ||
+ | <br> | ||
+ | <h4 align="left">8. Double digestion: PRE/pMD-19T and rbs+mRFP+tag-dT/pSB1C3:</h4> | ||
<img src="https://static.igem.org/mediawiki/2014/4/4c/HUST_protocol_12.png"></img> | <img src="https://static.igem.org/mediawiki/2014/4/4c/HUST_protocol_12.png"></img> | ||
- | < | + | <br> |
+ | <h4 align="left">9. Colony PCR Validation (primer PRE F and mRFP R1):</h4> | ||
<img src="https://static.igem.org/mediawiki/2014/f/f6/HUST_protocol_13.png"></img> | <img src="https://static.igem.org/mediawiki/2014/f/f6/HUST_protocol_13.png"></img> | ||
- | <p> | + | <p h5 align="left">The plasmid PRE-rbs+mRFP+tag-dT/pMD19-T was extracted and sequenced.</h4></p> |
- | <p> | + | <br> |
+ | <br> | ||
+ | <p><h3>step 2: Transformation of bacteria and colony PCR(primer VF2 and VR)</h3></p> | ||
+ | <h4 align="left">1. Promoter lambda (cI regulated) with GFP (+LVA) reporter in pSB1A3:</h4> | ||
<img src="https://static.igem.org/mediawiki/2014/5/59/HUST_protocol_14.png"></img> | <img src="https://static.igem.org/mediawiki/2014/5/59/HUST_protocol_14.png"></img> | ||
- | < | + | <h4 align="left">The plasmid PR-rbs+GFP+LVA/pSB1C3 was extracted and sequenced.</h4> |
- | < | + | <br> |
- | < | + | <h4 align="left">2. Double digestion:(3A assembly)</h4> |
+ | <h4 align="left"> PRE- rbs+mRFP+tag-dT/pMD19-T</h4> | ||
<img src="https://static.igem.org/mediawiki/2014/8/88/HUST_protocol_15.png"></img> | <img src="https://static.igem.org/mediawiki/2014/8/88/HUST_protocol_15.png"></img> | ||
- | < | + | <br> |
- | <img src="https://static.igem.org/mediawiki/2014/8/84/HUST_protocol_16.png"></img> | + | <br> |
- | <p> | + | <br> |
+ | <h4 align="left">3. PpcoA-rbs+CII+LVA-rbs+CI+tag-dT/pSB1C3</p> | ||
+ | <p style="align:left"><img src="https://static.igem.org/mediawiki/2014/8/84/HUST_protocol_16.png"></img></p> | ||
+ | <br> | ||
+ | <br> | ||
+ | <br> | ||
+ | <h3 align="left">4. Colony PCR validation (primer cI F and mRFP R1):</h4> | ||
<img src="https://static.igem.org/mediawiki/2014/6/6f/HUST_protocol_17.png"></img> | <img src="https://static.igem.org/mediawiki/2014/6/6f/HUST_protocol_17.png"></img> | ||
- | < | + | <h4 align="left">The plasmid PpcoA-rbs+CII+LVA-rbs+CI+tag-dT-PRE-rbs+mRFP+tag-dT/pSB1C3 was extracted and sequenced using primer VF2 and VR.</h4> |
- | < | + | <h3>5. Double digestion PR-rbs+GFP+LVA/pSB1C3</h3> |
<img src="https://static.igem.org/mediawiki/2014/7/7b/HUST_protocol_18.png"></img> | <img src="https://static.igem.org/mediawiki/2014/7/7b/HUST_protocol_18.png"></img> | ||
- | < | + | <br> |
+ | <br> | ||
+ | <br> | ||
+ | <h4 align="left">6. PpcoA-rbs+CII+LVA-rbs+CI+tag-dT-PRE-rbs+mRFP+tag-dT/pSB1C3</h4> | ||
<img src="https://static.igem.org/mediawiki/2014/1/10/HUST_protocol_19.png"></img> | <img src="https://static.igem.org/mediawiki/2014/1/10/HUST_protocol_19.png"></img> | ||
- | < | + | <br> |
+ | <h4 align="left">7. Colony PCR Validation (primer PRE F and GFP R):</h4> | ||
<img src="https://static.igem.org/mediawiki/2014/c/ce/HUST_protocol_20.png"></img> | <img src="https://static.igem.org/mediawiki/2014/c/ce/HUST_protocol_20.png"></img> | ||
- | <p> | + | <p><h4 align="left">The plasmid PpcoA-rbs+CII+LVA-rbs+CI+tag-dT-PRE-rbs+mRFP+tag-dT-PR-rbs+GFP+LVA/pSB1C3 was extracted and sequenced using primer VF2 and VR.</h4></p> |
- | <a name="Part_3" id="Part_3"></a | + | <br> |
- | < | + | <br> |
+ | <br> | ||
+ | |||
+ | |||
+ | <h1 align="left" id="h2_1"><a name="Part_3" id="Part_3"></a>Part 3: The Construction of the Kill Switch</h1> | ||
+ | <h3>Plasmid construction:</h3> | ||
<p>PCR: CI repressor from <em>E. coli</em> phage lambda (+LVA) in pSB1C3(BBa_C0051)was amplified to add RBS using primer:</p> | <p>PCR: CI repressor from <em>E. coli</em> phage lambda (+LVA) in pSB1C3(BBa_C0051)was amplified to add RBS using primer:</p> | ||
<p>cI F: 5'–TATGAATTCTCTAGATAAGGAGATATAATGAGCACAAAAAAG-3' and cI R: 5'–TAATCTGCAGACTAGTGCGATCTACACTAGCACTATC-3'</p> | <p>cI F: 5'–TATGAATTCTCTAGATAAGGAGATATAATGAGCACAAAAAAG-3' and cI R: 5'–TAATCTGCAGACTAGTGCGATCTACACTAGCACTATC-3'</p> | ||
<img src="https://static.igem.org/mediawiki/2014/4/48/HUST_protocol_20_5.png"></img> | <img src="https://static.igem.org/mediawiki/2014/4/48/HUST_protocol_20_5.png"></img> | ||
- | < | + | <br> |
- | < | + | <h3>Double digestion:<h3><p> PCR product of cI+rbs obtained using gel extraction kit and double terminator (dT) in pSB1C3 were applied to double digestion. The reaction systems were listed in table 3-1, 3-2.</p> |
+ | <h3 align="center">Table3-1 Digestion of Fragment (cI+rbs):</h3> | ||
<table border="1" cellpadding="1" cellspacing="0"> | <table border="1" cellpadding="1" cellspacing="0"> | ||
<tr> | <tr> | ||
Line 458: | Line 507: | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
- | <td> | + | <td>EcoRI</td> |
<td>2μl</td> | <td>2μl</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
- | <td> | + | <td>SpeI</td> |
<td>2 μl</td> | <td>2 μl</td> | ||
</tr> | </tr> | ||
Line 470: | Line 519: | ||
</tr> | </tr> | ||
</table> | </table> | ||
- | < | + | <br> |
+ | <h3 align="center">Table 3-2 Digestion of pSB1C3-dT:</h3> | ||
<table border="1" cellpadding="1" cellspacing="0"> | <table border="1" cellpadding="1" cellspacing="0"> | ||
<tr> | <tr> | ||
Line 481: | Line 531: | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
- | <td> | + | <td>EcoRI</td> |
<td>2μl</td> | <td>2μl</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
- | <td> | + | <td>SpeI</td> |
<td>2 μl</td> | <td>2 μl</td> | ||
</tr> | </tr> | ||
Line 496: | Line 546: | ||
<img src="https://static.igem.org/mediawiki/2014/9/9e/HUST_protocol_21.png"></img> | <img src="https://static.igem.org/mediawiki/2014/9/9e/HUST_protocol_21.png"></img> | ||
<p>Then, we linked them together at room temperature for 1h. The reaction system listed in table 3-3. </p> | <p>Then, we linked them together at room temperature for 1h. The reaction system listed in table 3-3. </p> | ||
- | < | + | <h3 align="center">Table 3-3 Reaction System of Ligation</h3> |
<table border="1" cellpadding="1" cellspacing="0"> | <table border="1" cellpadding="1" cellspacing="0"> | ||
<tr> | <tr> | ||
Line 515: | Line 565: | ||
</tr> | </tr> | ||
</table> | </table> | ||
- | < | + | <h3>Colony PCR validation:</h3> |
<p>Select monoclonal and applied to PCR:</p> | <p>Select monoclonal and applied to PCR:</p> | ||
<img src="https://static.igem.org/mediawiki/2014/2/2a/HUST_protocol_22.png"></img> | <img src="https://static.igem.org/mediawiki/2014/2/2a/HUST_protocol_22.png"></img> | ||
<p>The positive colone was cultured in LB overnight for plasmid extraction and sequencing.</p> | <p>The positive colone was cultured in LB overnight for plasmid extraction and sequencing.</p> | ||
+ | <br> | ||
<p>Assemble all elements one by one using the same method:</p> | <p>Assemble all elements one by one using the same method:</p> | ||
<p>Double digestion: </p> | <p>Double digestion: </p> | ||
- | < | + | <h3 >P<sub>L</sub> lacI (BBa_R0011) in pSB1A3 and pSB1C3-cI+rbs-dT</h3> |
<img src="https://static.igem.org/mediawiki/2014/4/46/HUST_protocol_23.png"></img> | <img src="https://static.igem.org/mediawiki/2014/4/46/HUST_protocol_23.png"></img> | ||
- | < | + | <br> |
+ | <h3>Colony PCR validation(primer VF2 and cI R):</h3> | ||
<img src="https://static.igem.org/mediawiki/2014/5/55/HUST_protocol_24.png"></img> | <img src="https://static.igem.org/mediawiki/2014/5/55/HUST_protocol_24.png"></img> | ||
- | < | + | <br> |
- | < | + | <h3>The plasmid PL lacI-rbs+cI-dT/pSB1C3 was extracted and sequenced.</h3> |
- | < | + | <h3>Double digestion:</h3> |
+ | <h3>P<sub>L</sub>/pMD-19T and rbs+mRFP+tag PCR products:</h3> | ||
<img src="https://static.igem.org/mediawiki/2014/1/12/HUST_protocol_25.png"></img> | <img src="https://static.igem.org/mediawiki/2014/1/12/HUST_protocol_25.png"></img> | ||
<p>Colony PCR validation(primer VF2 and mRFP R1):</p> | <p>Colony PCR validation(primer VF2 and mRFP R1):</p> | ||
<img src="https://static.igem.org/mediawiki/2014/1/14/HUST_protocol_26.png"></img> | <img src="https://static.igem.org/mediawiki/2014/1/14/HUST_protocol_26.png"></img> | ||
- | < | + | <br> |
+ | <h3>Colony PCR validation(primer VF2 and mRFP R1):</h3> | ||
- | < | + | <h3>The plasmid PL -rbs+mRFP+tag/pSB1C3 was extracted and sequenced.</h3> |
- | < | + | <h3>Double digestion:</p> |
- | < | + | <h3>P<sub>L</sub> -rbs+mRFP+tag/pMD19-T and PL lacI-rbs+cI-dT/pSB1C3:</h3> |
<img src="https://static.igem.org/mediawiki/2014/4/45/HUST_protocol_27.png"></img> | <img src="https://static.igem.org/mediawiki/2014/4/45/HUST_protocol_27.png"></img> | ||
- | < | + | <br> |
+ | <h3>Colony PCR validation (primer VF2 and cI R):</h3> | ||
<img src="https://static.igem.org/mediawiki/2014/8/8d/HUST_protocol_28.png"></img> | <img src="https://static.igem.org/mediawiki/2014/8/8d/HUST_protocol_28.png"></img> | ||
<p>The plasmid P<sub>L</sub> lacI-rbs+cI-dT- PL -rbs+mRFP+tag/pMD-19T was extracted and sequenced.</p> | <p>The plasmid P<sub>L</sub> lacI-rbs+cI-dT- PL -rbs+mRFP+tag/pMD-19T was extracted and sequenced.</p> | ||
- | <a name="Part_4" id="Part_4"></a | + | <br><br> |
- | + | <br> | |
+ | <h1 align="left" id="h2_1"><a name="Part_4" id="Part_4"></a>Part 4: Measuring of Growth Curve</h1> | ||
- | < | + | <h3 align="left">Step 1:</h2><p> 200μL overnight-cultured bacterial was added to vials containing newly prepared culture medium (containing 100μg/ml Kanamycin). Set one vial with culture medium as blank. All the samples were cultured in the shaking incubator with rotational speed at 200 rpm and temperature at 37℃.</p> |
- | < | + | <h3 align="left">Step 2:</h2><p> OD<sub>600</sub> values was measured using the nucleic acid analyzer. When the OD<sub>600</sub> values of culture reached 0.6, 200μL culture was added to a new vial containing 5mL LB, 100μg/ml Kanamycin, 0.1M IPTG and CN-/F-/Cu2+ with different concentration. Set one vial without bacteria as blank. All these samples were cultured in the shaking incubator with rotational speed at 200 rpm and temperature at 37℃.</p> |
- | <a name="Part_5" id="Part_5"></a | + | <h3 align="left">Step 3:</h2> <p> OD600 of samples from the vials were measured every 30 min. </p> |
- | < | + | <br><br> |
- | < | + | <br> |
- | < | + | <p h1 align="left" id="h2_1"><a name="Part_5" id="Part_5"></a>Part 5: The Standardization of Parts</h1></p> |
+ | <h2>Materials (used in this part)</h2> | ||
+ | <h4>The materials we used in this part are listed in table 5-1 and table 5-2</h3> | ||
+ | <h3 align="center">Table 5-1: Bacterial strains and plasmids</h3> | ||
<table border="1" cellpadding="1" cellspacing="0"> | <table border="1" cellpadding="1" cellspacing="0"> | ||
<tr> | <tr> | ||
Line 573: | Line 632: | ||
</tr> | </tr> | ||
</table> | </table> | ||
- | < | + | <br> |
+ | <h3 align="center">Table 5-2: Primers' Name and Sequence</h3> | ||
<table border="1" cellpadding="1" cellspacing="0"> | <table border="1" cellpadding="1" cellspacing="0"> | ||
<tr> | <tr> | ||
<td>Primer</td> | <td>Primer</td> | ||
- | <td>Sequence( | + | <td>Sequence(5’→3’)</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
- | <td>oprF | + | <td>oprF-F</td> |
<td>G GAATTC GCGGCCGC T TCTAGAG ATGAAACTGAAGAACACC</td> | <td>G GAATTC GCGGCCGC T TCTAGAG ATGAAACTGAAGAACACC</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
- | <td>oprF | + | <td>oprF-R</td> |
<td>TTT CTGCAG CGGCCGC T ACTAGT ACCAGCCGCCATGAT</td> | <td>TTT CTGCAG CGGCCGC T ACTAGT ACCAGCCGCCATGAT</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
- | <td>ompC | + | <td>ompC-F</td> |
<td>G GAATTC GCGGCCGC T TCTAGA G ATGCGTCTTGGCTT</td> | <td>G GAATTC GCGGCCGC T TCTAGA G ATGCGTCTTGGCTT</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
- | <td>ompC | + | <td>ompC-R</td> |
<td>TGCA CTGCAG CGGCCGC T ACTAGT ATTAGAACTGGTAAACC</td> | <td>TGCA CTGCAG CGGCCGC T ACTAGT ATTAGAACTGGTAAACC</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
- | <td>RTS | + | <td>RTS-F</td> |
<td>G GAATTC GCGGCCGC T TCTAGA G TCAGAACGGTTTGG</td> | <td>G GAATTC GCGGCCGC T TCTAGA G TCAGAACGGTTTGG</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
- | <td>RTS | + | <td>RTS-R</td> |
<td>TGCA CTGCAG CGGCCGC T ACTAGT ACTACCGTGATTCATTTC</td> | <td>TGCA CTGCAG CGGCCGC T ACTAGT ACTACCGTGATTCATTTC</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
- | <td>flA | + | <td>flA-F</td> |
<td>G GAATTC GCGGCCGC T TCTAGA G ATGGCTGCCAACAGCAC</td> | <td>G GAATTC GCGGCCGC T TCTAGA G ATGGCTGCCAACAGCAC</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
- | <td>flA | + | <td>flA-R</td> |
<td>TGCA CTGCAG CGGCCGC T ACTAGT ATCAGCGGGCCTCGACCC</td> | <td>TGCA CTGCAG CGGCCGC T ACTAGT ATCAGCGGGCCTCGACCC</td> | ||
</tr> | </tr> | ||
Line 644: | Line 704: | ||
</tr> | </tr> | ||
</table> | </table> | ||
- | < | + | <br> |
- | < | + | <h3 align="left">Step 1: Gene Standardized</h2> |
- | < | + | <h3>P4R amplification with the primers set as the template (pET28a-OprF-CBP/OprF-GS-CBP/<em>cyn</em>RTS composite/FLA). The conditions of the reaction were listed in table 5-3. </h3> |
+ | <h3 align="center">Table 5-3: The Reaction System to harvest target genes</h3> | ||
<table border="1" cellpadding="1" cellspacing="0"> | <table border="1" cellpadding="1" cellspacing="0"> | ||
<tr> | <tr> | ||
Line 681: | Line 742: | ||
</tr> | </tr> | ||
</table> | </table> | ||
- | < | + | <br> |
+ | <h3 align="left">Step 2: Obliteration of the Illegal Restriction Sites in the Gene</h2> | ||
<p>It is necessary to add standard restriction enzyme sites-EcoRI/XbaI/SpeI/PstI to both terminals of each gene. However, the sequence of ompC contains EcoRI, SpeI and PstI restriction site. So we obliterated the restriction sites by site-directed mutagenesis based on overlap extension PCR. Briefly, target mutation (GAATTC→GAGTTC, ACTAGT→GCTAGT , CTGCAG→CTCCAA, ) was introduced into primers (ompC-m-A/B/C/D/E/F/G/H in table 5-2), and the four previous PCR products(ompC-AB, ompC-CD, ompC-EF, ompC-GH) were used as template for the second PCR, and the two previous PCR products(ompC-AD, ompC-EH) were used as template for the third PCR. The final PCR segment with target mutation sites was then cloned into pMD18-T vector for sequencing. The three PCR systems were listed in table 5-4, 5-5, 5-6. </p> | <p>It is necessary to add standard restriction enzyme sites-EcoRI/XbaI/SpeI/PstI to both terminals of each gene. However, the sequence of ompC contains EcoRI, SpeI and PstI restriction site. So we obliterated the restriction sites by site-directed mutagenesis based on overlap extension PCR. Briefly, target mutation (GAATTC→GAGTTC, ACTAGT→GCTAGT , CTGCAG→CTCCAA, ) was introduced into primers (ompC-m-A/B/C/D/E/F/G/H in table 5-2), and the four previous PCR products(ompC-AB, ompC-CD, ompC-EF, ompC-GH) were used as template for the second PCR, and the two previous PCR products(ompC-AD, ompC-EH) were used as template for the third PCR. The final PCR segment with target mutation sites was then cloned into pMD18-T vector for sequencing. The three PCR systems were listed in table 5-4, 5-5, 5-6. </p> | ||
- | < | + | <h3 align="center">Table 5-4: Reaction System of the 1st PCR</h3> |
<table border="1" cellpadding="1" cellspacing="0"> | <table border="1" cellpadding="1" cellspacing="0"> | ||
<tr> | <tr> | ||
Line 710: | Line 772: | ||
</tr> | </tr> | ||
</table> | </table> | ||
- | < | + | <br> |
+ | <h3 align="center">Table 5-5: Reaction System of the 2nd PCR</h3> | ||
<table border="1" cellpadding="1" cellspacing="0"> | <table border="1" cellpadding="1" cellspacing="0"> | ||
<tr> | <tr> | ||
Line 737: | Line 800: | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
- | <td> | + | <td>H2O </td> |
<td>10</td> | <td>10</td> | ||
</tr> | </tr> | ||
</table> | </table> | ||
- | < | + | <br> |
+ | <h3 align="center">Table 5-6: Reaction System of 3rd PCR</h3> | ||
<table border="1" cellpadding="1" cellspacing="0"> | <table border="1" cellpadding="1" cellspacing="0"> | ||
<tr> | <tr> | ||
Line 768: | Line 832: | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
- | <td>H<sub> | + | <td>H<sub>2</sub>O </td> |
<td>10</td> | <td>10</td> | ||
</tr> | </tr> | ||
</table> | </table> | ||
- | < | + | <br> |
+ | <h3 align="left">Step 3: Insertion of the Standard Parts into plasmid backbone-pSB1C3</h2> | ||
<p>pSB1C3 backbone and the standardized parts was digested with EcoRI and PstI and then retrieved and purified with kits from Omega. pSB1C3 and the standardized parts were then linked together to from new Biobricks.</p> | <p>pSB1C3 backbone and the standardized parts was digested with EcoRI and PstI and then retrieved and purified with kits from Omega. pSB1C3 and the standardized parts were then linked together to from new Biobricks.</p> | ||
- | < | + | <br> |
+ | <h3 align="left">Step 4 : Submission of New Standardized Parts</h2> | ||
<p>After completing all the validation, the four parts were submitted to iGEM official organization in the early October and arrived in New York in 8th Oct. The information was listed in the table 5-7.</p> | <p>After completing all the validation, the four parts were submitted to iGEM official organization in the early October and arrived in New York in 8th Oct. The information was listed in the table 5-7.</p> | ||
<table border="1" cellpadding="1" cellspacing="0"> | <table border="1" cellpadding="1" cellspacing="0"> | ||
Line 783: | Line 849: | ||
<tr> | <tr> | ||
<td>pSB1C3-oprF-1(EcoRI PstI)</td> | <td>pSB1C3-oprF-1(EcoRI PstI)</td> | ||
- | <td>A major outer membrane protein of Pseudomonas aeruginosa functions as a nonspecific porin to allow the passage of small hydrophilic molecules. We cut the protein at | + | <td>A major outer membrane protein of <em>Pseudomonas aeruginosa</em> functions as a nonspecific porin to allow the passage of small hydrophilic molecules. We cut the protein at 188aa and add a CBP tag to C-terminal with a GS linker between them.</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td>pSB1C3-oprF-2(EcoRI PstI)</td> | <td>pSB1C3-oprF-2(EcoRI PstI)</td> | ||
- | <td>A major outer membrane protein of Pseudomonas aeruginosa functions as a nonspecific porin to allow the passage of small hydrophilic molecules. We cut the protein at | + | <td>A major outer membrane protein of <em>Pseudomonas aeruginosa<em> functions as a nonspecific porin to allow the passage of small hydrophilic molecules. We cut the protein at 196aa and add a CBP tag to C-terminal.</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td>pSB1C3-ompC(EcoRI PstI)</td> | <td>pSB1C3-ompC(EcoRI PstI)</td> | ||
- | <td>Outer membrane porin protein C from Escherichia coli BL21(DE3)</td> | + | <td>Outer membrane porin protein C from <em>Escherichia coli</em> BL21(DE3)</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td>pSB1C3-RTS(EcoRI PstI)</td> | <td>pSB1C3-RTS(EcoRI PstI)</td> | ||
- | <td>Cyn | + | <td>Cyn operon in <em>Escherichia coli</em> BL21(DE3) (cynR+cynT+cynS) is about cyanate detoxification.</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td>pSB1C3-FLA(EcoRI PstI)</td> | <td>pSB1C3-FLA(EcoRI PstI)</td> | ||
- | <td>Fluorinase enzyme from | + | <td>Fluorinase enzyme from Streptomyces cattleya catalyzing the formation of a C–F bond by combining S-adenosyl-L-methionine (SAM) and F- to generate 5’-fluoro-5’-deoxyadenosine (5’-FDA) and L-methionine.</td> |
</tr> | </tr> | ||
</table> | </table> | ||
+ | <br> | ||
</div> | </div> | ||
</div> | </div> | ||
- | <div id="side_bar"> | + | <div id="side_bar" background-color:transparent;> |
- | <div class="anchor-h2" id="h2num_1"><p class="h2_0"><a href="#Part_1">Worker System</a></p></div> | + | <div class="anchor-h2" id="h2num_1"><p style="text-align:right"class="h2_0"><a href="#Part_1">Worker System</a></p></div> |
- | <div class="anchor-h2" id="h2num_1"><p class="h2_1"><a href="#Part_2">Instructor System</a></p></div> | + | <div class="anchor-h2" id="h2num_1"><p style="text-align:right"class="h2_1"><a href="#Part_2">Instructor System</a></p></div> |
- | <div class="anchor-h2" id="h2num_1"><p class="h2_2"><a href="#Part_3">Kill Switch</a></p></div> | + | <div class="anchor-h2" id="h2num_1"><p style="text-align:right"class="h2_2"><a href="#Part_3">Kill Switch</a></p></div> |
- | <div class="anchor-h2" id="h2num_1"><p class="h2_2"><a href="#Part_4">Growth Curve</a></p></div> | + | <div class="anchor-h2" id="h2num_1"><p style="text-align:right"class="h2_2"><a href="#Part_4">Growth Curve</a></p></div> |
- | <div class="anchor-h2" id="h2num_1"><p class="h2_2"><a href="#Part_5">Standardization</a></p></div> | + | <div class="anchor-h2" id="h2num_1"><p style="text-align:right"class="h2_2"><a href="#Part_5">Standardization</a></p></div> |
</div> | </div> | ||
<div id="apDiv_BackToTop"><a href="#Top"><img src="https://static.igem.org/mediawiki/2014/d/d4/HUST_BackToTop.png" width="100" height="100" /></a></div> | <div id="apDiv_BackToTop"><a href="#Top"><img src="https://static.igem.org/mediawiki/2014/d/d4/HUST_BackToTop.png" width="100" height="100" /></a></div> | ||
+ | |||
+ | <div id="apDiv_Logo_iGEM"><a href="https://2014.igem.org/Main_Page"><img src="https://static.igem.org/mediawiki/2014/d/db/HUST_Logo_iGEM.png | ||
+ | " width="100" height="100" border="0"/></a></div> | ||
</div> | </div> |
Latest revision as of 01:51, 18 October 2014
oo
![](https://static.igem.org/mediawiki/2014/3/3b/HUST_Front.png)
Part 1: The Construction of the Worker System
Step 1: Gene Cloning
To find the optimal temperature for oprF and cynRTS composite amplification, we set a gradient of annealing temperature. The result shows that 58℃ is suitable to this PCR. The PCR product was stored in -20℃. The PCR reaction system was listed in table 1-1.
Table 1-1 Gradient PCR System
Components(50μl) | Volume(ml) |
PrimerStar Buffer | 10 |
dNTPs(2.5mM) | 5 |
Primer-F(10μM) | 1.5 |
Primer-R(10μM) | 1.5 |
Template | 1.5 |
PrimerStar | 0.5 |
ddH2O | 30 |
Step 2: Optimization of oprF
We choose the 188aa or 196aa of OprF as the CBP fusion points. Primers were designed (Table1-2) to clone the target fragment, and then the GS linker and/or the gene fragment coding CBP were added at the C-terminal of the target fragment.
The protein with GS linker, using the 188aa as CBP fusion point, was named as OprF-1. While the protein without GS linker, using the 196aa as CBP fusion point, was named as OprF-2.
Table 1-2 Primers of Optimization oprF
Primer | Sequence(5'→3') |
oprF-CBP-F | CCGGAATTCAACTGAAGAACACCTT |
oprF-CBP-R1 | CCAGCCGCCATGATGCGGGGAAACCGGTTCCGGAGCCGGAGCGGC |
oprF-CBP-R2 | ATAGTTTAGCGGCCGCCGGCCAGCCGCCATGATGCGGGGA |
oprF-GS-F | CCGGAATTCAACTGAAGAACACCTT |
oprF-GS-R1 | TGAACCTCCGCCACCTTTCGAACCACCGAAGTTGAAG |
oprF-GS-R2 | CCAGCCGCCATGATGCGGGGATGAACCTCCGCCACC |
oprF-GS-R3 | ATAGTTTAGCGGCCGCCGGCCAGCCGCCATGATGCGGGGA |
Step 3: Construction of Vectors
pET28a vector and the PCR product were digested with EcoRI and NotI from Takara, and then retrieved and purified with DNA retrieve kits from Omega.
Then, pET28a(+) vector, gene oprF-1/oprF-2/cynRTS composite were linked together with T4 ligase to form a new vector: pET28a(+)-oprF-1/oprF-2/RTS. The reaction system for digestion and conjunction were listed in the table 1-3, 1-4 and the digestion results were displayed in fig1-1.
Table 1-3 Reaction System for Digestion
Components(50μl) | Volume(μl) |
10×H Buffer | 5 |
BSA | 5 |
EcoRI | 2.5 |
NotI | 2.5 |
Fragment | 25 |
ddH2O | 10 |
Conditions | 37℃ 1h |
Table 1-4 for Gene Conjunction
Components | System components(10μl) |
Buffer(with T4 ligase) | 5 |
Insert | 4.5 |
Vector | 0.5 |
Conditions | 16℃ 1h |
Fig 1-1 Digested gene and plasmid
![](https://static.igem.org/mediawiki/2014/d/d6/HUST_protocol_01.png)
Step 4: Transforming the Plasmids into E. coli BL21 Strain
Step 4: Transforming the Plasmids into E. coli BL21 Strain
Plasmids pET28a(+)-oprF-1 or pET28a(+)-oprF-2 or pET28a(+)-flA was transformed into E. coli BL21(DE3) and protein expression was analyzed.The strains were grown in LB medium containing 100ug/ml kanamycin at 37℃, 250rpm until OD600 reached 0.4–0.6. We then added IPTG to 0.5mM and continued the incubation at 28℃ overnight to induce the overexpression of OprF-CBP or OprF-GS-CBP or flA. The cells were collected, re-suspended with 10mM imidazole containing 0.1mM protease inhibitor PMSF and then disrupted using Selecta Sonopuls. After centrifugation, the sediment was treated with 1xSDS gel loading buffer and kept in boiling water for 5 minutes and applied to SDS-PAGE. The result was displayed in Fig 1-4.
Table 1-5 Reaction System of Colonial PCR validation
Components(10μl) | Volume(ml) |
2×Ex Taq Mix | 5 |
Primer-F(10μmol/L) | 0.3 |
Primer-R(10μmol/L) | 0.3 |
Template | 0.3 |
H2O | 4.1 |
Table 1-6 Reaction System of Double Digestion (37 ℃ 1h)
Components(10μl) | Volume(μl) |
10×H Buffer | 1 |
BSA | 1 |
EcoRI | 0.5 |
NotI | 0.5 |
ddH2O | 7 |
![](https://static.igem.org/mediawiki/2014/1/1f/HUST_protocol_02.png)
Fig 1-2 Gel images of novel plasmids with OprF-CBP/GS-CBP testified results
![](https://static.igem.org/mediawiki/2014/5/55/HUST_protocol_03.png)
Fig 1-3 Gel images of novel plasmids with cynRTS composite testified results
The E. coli BL21(DE3) strain transformed with pET28a(+)-flA was kindly donated by Prof. David O'Hagan and Prof. James H. Naismith from University of St Andrews, Saint Andrews, Scotland, United Kingdom.
Step 5: Expression of Protein
Plasmid pET28a(+)-oprF-1/oprF-2/cynRTS composite/flA was transformed into E. coli BL21(DE3) and we get for protein expression analysis. The strains were grown in Luria broth containing 100ug/ml kanamycin at 37℃, 250rpm until an absorbance of 0.4–0.6 at 600 nm was reached. We then added IPTG to 0.5mM and continued the incubation at 28℃ overnight to induce the overexpression of OprF-CBP/OprF-GS-CBP. The cells were collected, suspended with 10mM imidazole containing 0.1mM protease inhibitor PMSF and then disrupted using Selecta Sonopuls. After centrifugation, the sediment was treated with 1*SDS gel loading buffer and kept in boiling water for 5 minutes and applied to SDS-PAGE.
Step 6: Surface Displaying Copper Ions
To identify that whether our OprF has anchored on the cell membrane of E. coli, we performed immunofluorescence assay. HA tag was added to the N-terminal of OprF-CBP so that the recombinant protein OprF-CBP-HA can be specifically recognized by anti-HA antibody. When FITC labeled anti-IgG antibody was used as the secondary antibody and interacted with the primary antibody, green fluorescence could be observed in the cell membrane of E. coli under the fluorescent microscope.
Part 2: The Construction of the Instructor System
All the parts except PpcoA we used to construct E. instructor are from kits in Distribution 2013.They are listed in table2-1.
Table 2-1 Parts from Kits in Distribution 2013
Name | Parts | Well | Short Description |
CII | BBa_P0153 | 9A(plate3,2013) | Protein |
CI | BBa_C0051 | 3A(plate3,2013) | Protein |
RFP | BBa_E1010 | 18F(plate5,2013) | engineered mutant of red fluorescent protein |
GFP | BBa_E0044 | 14G(plate5,2013) | mGFP mut3b+AAV |
PR | BBa_R0051 | 6K(plate5,2013) | CI regulated promoter |
PRE | BBa_R0053 | 6M(plate5,2013) | CII regulated promoter |
Assemble all the elements via standard restrict sites:
1. PCR: PpcoA (add EcoRI, XbaI, SpeI and PstI restriction sites)
![](https://static.igem.org/mediawiki/2014/d/d3/HUST_protocol_05.png)
2. Double digestion: PpcoA PCR products and rbs+CII(LVA)+ter+ter/pSB1C3(BBa_P0153):
![](https://static.igem.org/mediawiki/2014/9/95/HUST_protocol_06.png)
3. Colony PCR Validation (primer PpcoA F and PpcoA R):
![](https://static.igem.org/mediawiki/2014/6/63/HUST_protocol_07.png)
The plasmid pPcoA-rbs+CII+LVA/pSB1C3 was extracted and sequenced.
4. Double digestion: PpcoA-rbs+CII+LVA/pSB1C3 and rbs+CI+tag-dT:
![](https://static.igem.org/mediawiki/2014/f/f2/HUST_protocol_08.png)
5. Colony PCR Validation(primer PpcoA F and cI R):
![](https://static.igem.org/mediawiki/2014/3/39/HUST_protocol_09.png)
The plasmid PpcoA-rbs+CII+LVA-rbs+CI+tag-dT/pSB1C3 was extracted and sequenced.
6. Double digestion: PCR product of rbs+mRFP+tag and dT/pSB1C3:
7. Colony PCR Validation (primer mRFP F1 and mRFP R1):
The plasmid rbs+mRFP+tag-dT/pSB1C3 were extracted and sequenced.
8. Double digestion: PRE/pMD-19T and rbs+mRFP+tag-dT/pSB1C3:
![](https://static.igem.org/mediawiki/2014/4/4c/HUST_protocol_12.png)
9. Colony PCR Validation (primer PRE F and mRFP R1):
![](https://static.igem.org/mediawiki/2014/f/f6/HUST_protocol_13.png)
The plasmid PRE-rbs+mRFP+tag-dT/pMD19-T was extracted and sequenced.
step 2: Transformation of bacteria and colony PCR(primer VF2 and VR)
1. Promoter lambda (cI regulated) with GFP (+LVA) reporter in pSB1A3:
![](https://static.igem.org/mediawiki/2014/5/59/HUST_protocol_14.png)
The plasmid PR-rbs+GFP+LVA/pSB1C3 was extracted and sequenced.
2. Double digestion:(3A assembly)
PRE- rbs+mRFP+tag-dT/pMD19-T
![](https://static.igem.org/mediawiki/2014/8/88/HUST_protocol_15.png)
3. PpcoA-rbs+CII+LVA-rbs+CI+tag-dT/pSB1C3
4. Colony PCR validation (primer cI F and mRFP R1):
The plasmid PpcoA-rbs+CII+LVA-rbs+CI+tag-dT-PRE-rbs+mRFP+tag-dT/pSB1C3 was extracted and sequenced using primer VF2 and VR.
5. Double digestion PR-rbs+GFP+LVA/pSB1C3
6. PpcoA-rbs+CII+LVA-rbs+CI+tag-dT-PRE-rbs+mRFP+tag-dT/pSB1C3
7. Colony PCR Validation (primer PRE F and GFP R):
The plasmid PpcoA-rbs+CII+LVA-rbs+CI+tag-dT-PRE-rbs+mRFP+tag-dT-PR-rbs+GFP+LVA/pSB1C3 was extracted and sequenced using primer VF2 and VR.
Part 3: The Construction of the Kill Switch
Plasmid construction:
PCR: CI repressor from E. coli phage lambda (+LVA) in pSB1C3(BBa_C0051)was amplified to add RBS using primer:
cI F: 5'–TATGAATTCTCTAGATAAGGAGATATAATGAGCACAAAAAAG-3' and cI R: 5'–TAATCTGCAGACTAGTGCGATCTACACTAGCACTATC-3'
![](https://static.igem.org/mediawiki/2014/4/48/HUST_protocol_20_5.png)
Double digestion:
PCR product of cI+rbs obtained using gel extraction kit and double terminator (dT) in pSB1C3 were applied to double digestion. The reaction systems were listed in table 3-1, 3-2.
Table3-1 Digestion of Fragment (cI+rbs):
Reaction system | 50 μl |
DNA solution | 41 μl |
EcoRI | 2μl |
SpeI | 2 μl |
10×H | 5 μl |
Table 3-2 Digestion of pSB1C3-dT:
Reaction system | 50 μl |
plasmid | 41 μl |
EcoRI | 2μl |
SpeI | 2 μl |
10×M | 5 μl |
The mixture was incubated in 37℃ for 2h , then gel electrophoresis and gel extraction were performed:
![](https://static.igem.org/mediawiki/2014/9/9e/HUST_protocol_21.png)
Then, we linked them together at room temperature for 1h. The reaction system listed in table 3-3.
Table 3-3 Reaction System of Ligation
Ligation system | 10μl |
cI+rbs | 4μl |
Vector | 1μl |
T4 Ligase(contain 10x T4 Ligase Buffer) | 5μl |
Colony PCR validation:
Select monoclonal and applied to PCR:
![](https://static.igem.org/mediawiki/2014/2/2a/HUST_protocol_22.png)
The positive colone was cultured in LB overnight for plasmid extraction and sequencing.
Assemble all elements one by one using the same method:
Double digestion:
PL lacI (BBa_R0011) in pSB1A3 and pSB1C3-cI+rbs-dT
![](https://static.igem.org/mediawiki/2014/4/46/HUST_protocol_23.png)
Colony PCR validation(primer VF2 and cI R):
![](https://static.igem.org/mediawiki/2014/5/55/HUST_protocol_24.png)
The plasmid PL lacI-rbs+cI-dT/pSB1C3 was extracted and sequenced.
Double digestion:
PL/pMD-19T and rbs+mRFP+tag PCR products:
![](https://static.igem.org/mediawiki/2014/1/12/HUST_protocol_25.png)
Colony PCR validation(primer VF2 and mRFP R1):
![](https://static.igem.org/mediawiki/2014/1/14/HUST_protocol_26.png)
Colony PCR validation(primer VF2 and mRFP R1):
The plasmid PL -rbs+mRFP+tag/pSB1C3 was extracted and sequenced.
Double digestion:
PL -rbs+mRFP+tag/pMD19-T and PL lacI-rbs+cI-dT/pSB1C3:
Colony PCR validation (primer VF2 and cI R):
The plasmid PL lacI-rbs+cI-dT- PL -rbs+mRFP+tag/pMD-19T was extracted and sequenced.
Part 4: Measuring of Growth Curve
Step 1:
200μL overnight-cultured bacterial was added to vials containing newly prepared culture medium (containing 100μg/ml Kanamycin). Set one vial with culture medium as blank. All the samples were cultured in the shaking incubator with rotational speed at 200 rpm and temperature at 37℃.
Step 2:
OD600 values was measured using the nucleic acid analyzer. When the OD600 values of culture reached 0.6, 200μL culture was added to a new vial containing 5mL LB, 100μg/ml Kanamycin, 0.1M IPTG and CN-/F-/Cu2+ with different concentration. Set one vial without bacteria as blank. All these samples were cultured in the shaking incubator with rotational speed at 200 rpm and temperature at 37℃.
Step 3:
OD600 of samples from the vials were measured every 30 min.
Part 5: The Standardization of Parts
Materials (used in this part)
The materials we used in this part are listed in table 5-1 and table 5-2
Table 5-1: Bacterial strains and plasmids
Strains and vectors | Relevant genotype and characteristics | Originate | |
E. coli DH5α | Strains | conserved in the lab | |
pMD18T | Vectors | TaKaRa Biotechnology (DaLian)Co.,Ltd. | |
pSB1C3 | Vectors | iGEM package |
Table 5-2: Primers' Name and Sequence
Primer | Sequence(5’→3’) |
oprF-F | G GAATTC GCGGCCGC T TCTAGAG ATGAAACTGAAGAACACC |
oprF-R | TTT CTGCAG CGGCCGC T ACTAGT ACCAGCCGCCATGAT |
ompC-F | G GAATTC GCGGCCGC T TCTAGA G ATGCGTCTTGGCTT |
ompC-R | TGCA CTGCAG CGGCCGC T ACTAGT ATTAGAACTGGTAAACC |
RTS-F | G GAATTC GCGGCCGC T TCTAGA G TCAGAACGGTTTGG |
RTS-R | TGCA CTGCAG CGGCCGC T ACTAGT ACTACCGTGATTCATTTC |
flA-F | G GAATTC GCGGCCGC T TCTAGA G ATGGCTGCCAACAGCAC |
flA-R | TGCA CTGCAG CGGCCGC T ACTAGT ATCAGCGGGCCTCGACCC |
ompC-m-A | CCGCTTCTAGAGATGCGTCTTGGCTT |
ompC-m-B | GGTGTCACCACCGAACTCTGGCAGT |
ompC-m-C | ACTGCCAGAGTTCGGTGGTGACACC |
ompC-m-D | GTTACGCCACTAGTAAAGCCTTCAC |
ompC-m-E | ATTGCAGGTAAGCCAGGGACGGACG |
ompC-m-F | GTGAAGGCTTTGCTAGTGGCGTAAC |
ompC-m-G | CGTCCGTCCCTGGCTTACCTGCAAT |
ompC-m-H | CCGCTACTAGTATTAGAACTGGTAAACC |
Step 1: Gene Standardized
P4R amplification with the primers set as the template (pET28a-OprF-CBP/OprF-GS-CBP/cynRTS composite/FLA). The conditions of the reaction were listed in table 5-3.
Table 5-3: The Reaction System to harvest target genes
Components(50μl) | Volume(μl) |
Template | 1.25 |
dNTPs | 2.5 |
10×LA PCR Buffer | 5 |
LA Tag | 0.5 |
Primer-F(10μmol/L) | 2.5 |
Primer-R(10μmol/L) | 2.5 |
ddH2O | 35.75 |
Step 2: Obliteration of the Illegal Restriction Sites in the Gene
It is necessary to add standard restriction enzyme sites-EcoRI/XbaI/SpeI/PstI to both terminals of each gene. However, the sequence of ompC contains EcoRI, SpeI and PstI restriction site. So we obliterated the restriction sites by site-directed mutagenesis based on overlap extension PCR. Briefly, target mutation (GAATTC→GAGTTC, ACTAGT→GCTAGT , CTGCAG→CTCCAA, ) was introduced into primers (ompC-m-A/B/C/D/E/F/G/H in table 5-2), and the four previous PCR products(ompC-AB, ompC-CD, ompC-EF, ompC-GH) were used as template for the second PCR, and the two previous PCR products(ompC-AD, ompC-EH) were used as template for the third PCR. The final PCR segment with target mutation sites was then cloned into pMD18-T vector for sequencing. The three PCR systems were listed in table 5-4, 5-5, 5-6.
Table 5-4: Reaction System of the 1st PCR
Components(50μl) | Volume(μl) |
2×Ex Taq Mix | 25 |
ompC-m-A/C/E/G(10μM) | 1.5 |
ompC-m-B/D/F/H(10μM) | 1.5 |
Template | 1.5 |
H2O | 20.5 |
Table 5-5: Reaction System of the 2nd PCR
Components(50μl) | Volume(μl) |
2×Ex Taq Mix | 25 |
ompC-A/E(10μM) | 2.5 |
ompC-D/H(10μM) | 2.5 |
ompC-AB/EF | 5 |
ompC-CD/GH | 5 |
H2O | 10 |
Table 5-6: Reaction System of 3rd PCR
Components(50μl) | Volume(μl) |
2×Ex Taq Mix | 25 |
ompC-F(10μM) | 2.5 |
ompC-R(10μM) | 2.5 |
ompC-AD | 5 |
ompC-EH | 5 |
H2O | 10 |
Step 3: Insertion of the Standard Parts into plasmid backbone-pSB1C3
pSB1C3 backbone and the standardized parts was digested with EcoRI and PstI and then retrieved and purified with kits from Omega. pSB1C3 and the standardized parts were then linked together to from new Biobricks.
Step 4 : Submission of New Standardized Parts
After completing all the validation, the four parts were submitted to iGEM official organization in the early October and arrived in New York in 8th Oct. The information was listed in the table 5-7.
Standard biobricks | description |
pSB1C3-oprF-1(EcoRI PstI) | A major outer membrane protein of Pseudomonas aeruginosa functions as a nonspecific porin to allow the passage of small hydrophilic molecules. We cut the protein at 188aa and add a CBP tag to C-terminal with a GS linker between them. |
pSB1C3-oprF-2(EcoRI PstI) | A major outer membrane protein of Pseudomonas aeruginosa functions as a nonspecific porin to allow the passage of small hydrophilic molecules. We cut the protein at 196aa and add a CBP tag to C-terminal. |
pSB1C3-ompC(EcoRI PstI) | Outer membrane porin protein C from Escherichia coli BL21(DE3) |
pSB1C3-RTS(EcoRI PstI) | Cyn operon in Escherichia coli BL21(DE3) (cynR+cynT+cynS) is about cyanate detoxification. |
pSB1C3-FLA(EcoRI PstI) | Fluorinase enzyme from Streptomyces cattleya catalyzing the formation of a C–F bond by combining S-adenosyl-L-methionine (SAM) and F- to generate 5’-fluoro-5’-deoxyadenosine (5’-FDA) and L-methionine. |
E-mail: byl.hust.china@gmail.com
HUST, China